Dolby Laboratories (MEX:DLB) Other Long-Term Liabilities: MXN528 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DLB Dolby Laboratories Inc MEX:DLB
77 GF Score
Price MXN933.45
GF Value MXN1,196.51
! 4 Warning Signs
View Full Analysis

What is Dolby Laboratories Other Long-Term Liabilities?

Dolby Laboratories MEX:DLB 77 Other Long-Term Liabilities is MXN528 Mil as of Jun. 2026. GuruFocus rates MEX:DLB with a GF Score™ of 77/100 and a GF Value™ of MXN1,196.51. The stock has 4 warning signs investors should review.

Dolby Laboratories's other long-term liabilities for the quarter that ended in Jun. 2026 was MXN528 Mil.

Dolby Laboratories's quarterly other long-term liabilities declined from Dec. 2025 (MXN698 Mil) to Mar. 2026 (MXN545 Mil) and declined from Mar. 2026 (MXN545 Mil) to Jun. 2026 (MXN528 Mil).

Dolby Laboratories's annual other long-term liabilities increased from Sep. 2023 (MXN515 Mil) to Sep. 2024 (MXN1,035 Mil) but then declined from Sep. 2024 (MXN1,035 Mil) to Sep. 2025 (MXN887 Mil).

Dolby Laboratories Other Long-Term Liabilities Related Terms

Dolby Laboratories Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Dolby Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolby Laboratories Other Long-Term Liabilities Chart

Dolby Laboratories Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 316.04 246.15 514.81 1,034.75 887.29

Dolby Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 803.69 887.29 697.92 545.15 528.36
MEX:DLB
77GF Score
Dolby Laboratories Inc MEX:DLB
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dolby Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of MXN528 Mil mean?
Dolby Laboratories (MEX:DLB) has a Other Long-Term Liabilities of MXN528 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dolby Laboratories and its competitors.
Is Dolby Laboratories' Other Long-Term Liabilities too high?
Dolby Laboratories' current Other Long-Term Liabilities is MXN528 Mil. Overall, Dolby Laboratories has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Dolby Laboratories' Other Long-Term Liabilities compare to AZZ and UNF?
Dolby Laboratories' Other Long-Term Liabilities of MXN528 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Business Services company?
A good Other Long-Term Liabilities depends on the Business Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Dolby Laboratories and its competitors. Dolby Laboratories's current Other Long-Term Liabilities is MXN528 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolby Laboratories stock overvalued right now?
Dolby Laboratories (MEX:DLB) has a current Other Long-Term Liabilities of MXN528 Mil. The stock's GF Value™ is MXN1,196.51, compared to a current price of MXN933.45 — trading 22% below its estimated fair value. The current Other Long-Term Liabilities is MXN528 Mil. Dolby Laboratories' overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Dolby Laboratories (MEX:DLB), the current Other Long-Term Liabilities is MXN528 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dolby Laboratories (MEX:DLB) Overvalued in 2026?

Based on GuruFocus' analysis, Dolby Laboratories stock appears to be undervalued. The current stock price of MXN933.45 is trading 22% below its estimated GF Value™ of MXN1,196.51.

Key valuation signals for MEX:DLB:

  • Other Long-Term Liabilities: MXN528 Mil
  • GF Value™: MXN1,196.51 vs. price of MXN933.45 (22% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the MEX:DLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dolby Laboratories Business Description

Address 1275 Market Street, San Francisco, CA, USA, 94103-1410
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
77GF Score

Get the complete analysis for MEX:DLB

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN933.45
Price
MXN1,196.51
GF Value